Vanda Pharmaceuticals
Washington D.C., District of Columbia, 20037, United States
Location status: Recruiting
Recruiting
NCT Number: NCT03154697
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
3 year–65 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Parent or legal guardian of individual with Smith-Magenis Syndrome
Exclusion criteria
- Not legal guardian of individual with SMS
Treatment and study plan
Data collection of sleep disturbances in individuals with SMS
OtherData related to Smith-Magenis syndrome and sleep disturbances are collected through a web or phone survey
Primary outcomes
-
Number of individuals with Smith- Magenis syndrome
Time frame: 5 years
Secondary outcomes
-
Sleep Disturbances
Time frame: Up to 100 weeks
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Vanda Pharmaceuticals
Industry
Registry information
Official study title
Development of Clinical Database of Individuals With Smith-Magenis Syndrome
Important dates
- Study start
- 2016
- Primary completion
- 2030
- Study completion
- 2030
- First posted
- May 16, 2017
- Registry last updated
- Mar 20, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.